» Articles » PMID: 19326077

Induction of Pacemaker Currents by DA-9701, a Prokinetic Agent, in Interstitial Cells of Cajal from Murine Small Intestine

Overview
Journal Mol Cells
Publisher Elsevier
Date 2009 Mar 28
PMID 19326077
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The interstitial cells of Cajal (ICC) are pacemaking cells required for gastrointestinal motility. The possibility of whether DA-9701, a novel prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber, modulates pacemaker activities in the ICC was tested using the whole cell patch clamp technique. DA-9701 produced membrane depolarization and increased tonic inward pacemaker currents in the voltage-clamp mode. The application of flufenamic acid, a non-selective cation channel blocker, but not niflumic acid, abolished the generation of pacemaker currents induced by DA-9701. Pretreatment with a Ca2+-free solution and thapsigargin, a Ca2+-ATPase inhibitor in the endoplasmic reticulum, abolished the generation of pacemaker currents. In addition, the tonic inward currents were inhibited by U-73122, an active phospholipase C inhibitor, but not by GDP-beta-S, which permanently binds G-binding proteins. Furthermore, the protein kinase C inhibitors, chelerythrine and calphostin C, did not block the DA-9701-induced pacemaker currents. These results suggest that DA-9701 might affect gastrointestinal motility by the modulation of pacemaker activity in the ICC, and the activation is associated with the non-selective cationic channels via external Ca2+ influx, phospholipase C activation, and Ca2+ release from internal storage in a G protein-independent and protein kinase C-independent manner.

Citing Articles

A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study.

Lee J, Kim N, Yoon H, Shin C, Park Y, Lee D J Neurogastroenterol Motil. 2022; 28(2):265-275.

PMID: 35232894 PMC: 8978125. DOI: 10.5056/jnm20236.


Effect of DA-9701 on the Gastrointestinal Motility in the Streptozotocin-Induced Diabetic Mice.

Ha C, Kim H, Cha R, Lee J, Lee S, Ryu J J Clin Med. 2021; 10(22).

PMID: 34830563 PMC: 8623860. DOI: 10.3390/jcm10225282.


Double-Blind, Randomized, Placebo-Controlled Trial of DA-9701 in Parkinson's Disease: PASS-GI Study.

Choi J, Lee J, Cho J, Koh S, Yang Y, Yoo D Mov Disord. 2020; 35(11):1966-1976.

PMID: 32761955 PMC: 7754502. DOI: 10.1002/mds.28219.


DA-9701 (Motilitone): A Multi-Targeting Botanical Drug for the Treatment of Functional Dyspepsia.

Jin M, Son M Int J Mol Sci. 2018; 19(12).

PMID: 30551633 PMC: 6321359. DOI: 10.3390/ijms19124035.


Effect of DA-9701, a Novel Prokinetic Agent, on Post-operative Ileus in Rats.

Lee S, Lee O, Lee K, Lee H, Choi H, Yoon B J Neurogastroenterol Motil. 2016; 23(1):109-116.

PMID: 27832682 PMC: 5216641. DOI: 10.5056/jnm16003.